PubRank

Anette Sommer

Author PubWeight™ 21.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. Clin Cancer Res 2008 2.56
2 Distinct gene expression patterns in a tamoxifen-sensitive human mammary carcinoma xenograft and its tamoxifen-resistant subline MaCa 3366/TAM. Mol Cancer Ther 2005 1.33
3 Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogen-resistant derivative T47D-r. Mol Cell Proteomics 2003 1.10
4 DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterus. Mol Endocrinol 2009 1.05
5 Molecular profiles and clinical outcome of stage UICC II colon cancer patients. Int J Colorectal Dis 2011 1.05
6 Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancer. Clin Cancer Res 2010 1.02
7 Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer. BMC Genomics 2010 1.01
8 HDAC11 is a novel drug target in carcinomas. Int J Cancer 2012 0.93
9 What makes a good drug target? Drug Discov Today 2011 0.92
10 Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models. Int J Oncol 2009 0.90
11 Aspects of lung cancer gene expression profiling. Curr Opin Drug Discov Devel 2004 0.87
12 Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis. Cancer Med 2014 0.84
13 Tissue remodeling and nonendometrium-like menstrual cycling are hallmarks of peritoneal endometriosis lesions. Reprod Sci 2012 0.82
14 Grants4Targets - an innovative approach to translate ideas from basic research into novel drugs. Drug Discov Today 2010 0.80
15 Antiproliferative effects of DNA methyltransferase 3B depletion are not associated with DNA demethylation. PLoS One 2012 0.80
16 Global gene expression profiling of progesterone receptor modulators in T47D cells provides a new classification system. J Steroid Biochem Mol Biol 2008 0.79
17 What makes a good drug target? Drug Discov Today 2011 0.78
18 Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines. Front Oncol 2011 0.77
19 Molecular mode of action and role of TP53 in the sensitivity to the novel epothilone sagopilone (ZK-EPO) in A549 non-small cell lung cancer cells. PLoS One 2011 0.77
20 Novel molecular aspects of prostate carcinogenesis. Biomed Pharmacother 2004 0.76
21 HMGA proteins regulate the expression of FGF2 in uterine fibroids. Mol Hum Reprod 2010 0.76
22 Isogenic human mammary epithelial cell lines: novel tools for target identification and validation. Comprehensive characterization of an isogenic human mammary epithelial cell model provides evidence for epithelial-mesenchymal transition. Breast Cancer Res Treat 2013 0.75
23 5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis. Cancer Cell Int 2012 0.75